Corticosteroid-Sparing Effects of Filgotinib in Moderately to Severely Active Ulcerative Colitis: Data from the Phase 2b/3 SELECTION Study

por Loftus, Edward V, Vermeire, Séverine, Feagan, Brian G, Le Brun, Franck-Olivier, Oortwijn, Alessandra, Moerch, Ulrik, Sandborn, William J, Hibi, Toshifumi
Publicado 2022

Filgotinib Improved Health-Related Quality of Life and Led to Comprehensive Disease Control in Individuals with Ulcerative Colitis: Data from the SELECTION Trial

por Schreiber, Stefan, Feagan, Brian G, Peyrin-Biroulet, Laurent, Vermeire, Séverine, Faes, Margaux, Harris, Kristina, Oortwijn, Alessandra, Daniele, Patrick, Patel, Haridarshan, Danese, Silvio
Publicado 2023

Efficacy of Filgotinib in Patients with Ulcerative Colitis by Line of Therapy in the Phase 2b/3 SELECTION Trial

por Dotan, Iris, Feagan, Brian G, Taliadouros, Virginia, Oortwijn, Alessandra, Rudolph, Christine, de Haas, Angela, Santermans, Eva, Hsieh, Jeremy, Peyrin-Biroulet, Laurent, Hibi, Toshifumi
Publicado 2023

Rapid and Sustained Symptom Relief in Patients With Ulcerative Colitis Treated With Filgotinib: Data From the Phase 2b/3 SELECTION Trial

por Danese, Silvio, Ferrante, Marc, Feagan, Brian G., Peyrin-Biroulet, Laurent, Hibi, Toshifumi, Sandborn, William J., Schreiber, Stefan, Ritter, Timothy, Loftus, Edward V., Rogler, Gerhard, Oortwijn, Alessandra, Yun, Chohee, Le Brun, Franck-Olivier, Dinoso, Jason, Hsieh, Jeremy, Vermeire, Séverine
Publicado 2023

MANTA and MANTA-RAy: Rationale and Design of Trials Evaluating Effects of Filgotinib on Semen Parameters in Patients with Inflammatory Diseases

por Hellstrom, Wayne J. G., Dolhain, Radboud J. E. M., Ritter, Timothy E., Watkins, Timothy R., Arterburn, Sarah J., Dekkers, Goele, Gillen, Angi, Tonussi, Caroline, Gilles, Leen, Oortwijn, Alessandra, Van Beneden, Katrien, de Vries, Dick E., Sikka, Suresh C., Vanderschueren, Dirk, Reinisch, Walter
Publicado 2022